Grant Langdon
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
-
- HIV/AIDS drug development and treatment 6
- Tuberculosis Research and Epidemiology 5
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Helen McIlleron (6 shared papers)Justin J. Wilkins (6 shared papers)Ulrika S. H. Simonsson (5 shared papers)Peter John Smith (5 shared papers)Goonaseelan Colin Pillai (4 shared papers)Mats O. Karlsson (2 shared papers)Peter C. Kiessling (2 shared papers)Stephen R.A. Jolles (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (4 papers)European Journal of Clinical Pharmacology (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)International Journal of Pharmaceutics (1 paper)Blood Advances (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Grant Langdon
24 papers receiving 806 citations
Peers
Comparison fields: 5 of 70
- Infectious Diseases 284
- Pharmacology 74
- Hematology 87
- Pharmacology 90
- Neurology 73
Countries citing papers authored by Grant Langdon
This map shows the geographic impact of Grant Langdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant Langdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant Langdon more than expected).
Fields of papers citing papers by Grant Langdon
This network shows the impact of papers produced by Grant Langdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant Langdon. The network helps show where Grant Langdon may publish in the future.
Co-authors
The 25 scholars most cited alongside Grant Langdon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 173 | |
| 2 | 2008 | 133 | |
| 3 | 2020 | 91 | |
| 4 | 2011 | 90 | |
| 5 | 2006 | 69 | |
| 6 | 2020 | 50 | |
| 7 | 2020 | 35 | |
| 8 | 2007 | 31 | |
| 9 | 2021 | 27 | |
| 10 | Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis. | 2004 | 22 |
| 11 | 2025 | 15 | |
| 12 | 2005 | 15 | |
| 13 | 2009 | 14 | |
| 14 | 2011 | 11 | |
| 15 | 2012 | 10 | |
| 16 | 2011 | 9 | |
| 17 | 2006 | 7 | |
| 18 | 2010 | 7 | |
| 19 | 2011 | 7 | |
| 20 | 2005 | 4 |
About Grant Langdon
Grant Langdon is a scholar working on Infectious Diseases, Pharmacology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Epidemiology, having authored 24 papers that have together received 831 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), Tuberculosis Research and Epidemiology (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Malaria Research and Control (3 papers), Autoimmune Bullous Skin Diseases (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Complement system in diseases (1 paper). The work is most often cited by research in Infectious Diseases (284 citations), Pharmacology (74 citations), Hematology (87 citations), Pharmacology (90 citations) and Neurology (73 citations). Grant Langdon has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Helen McIlleron, Justin J. Wilkins, Ulrika S. H. Simonsson, Peter John Smith, Goonaseelan Colin Pillai, Mats O. Karlsson, Peter C. Kiessling, Stephen R.A. Jolles, Radojka M. Savić and Muhammad Hassan Bari. Their work appears in journals such as British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.